Jiangxi Fushine Pharmaceutical Co., Ltd.

Jiangxi Fushine Pharmaceutical Co., Ltd.

Jiangxi Fushine Pharmaceutical Co., Ltd.

Overview
Date Founded

2002

Headquarters

Junction of Yushan & Liyang,No. 2 Yuli Industrial Zone,Changjiang District,Jingdezhen, Jiangxi 333000

Type of Company

Public

Employees (Worldwide)

1,219

Industries

Pharmaceuticals
Retail: Drug Stores

Company Description

Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of active pharmaceutical ingredient (API) and pharmaceutical intermediates. It focuses on penicillin and its API and intermediates, and carbapenem and its API and intermediates. The company was founded in December 2002 and is headquartered in Jingdezhen, China.

Website
Executives & Employees

Chairman

Director & Executive Deputy General Manager

General Manager

Director

Subscribe now to see full list of current and former executives
Board of Directors

Chairman at Jiangxi Fushine Pharmaceutical Co., Ltd.

Former Secretary & Deputy General Manager at Zhejiang Yongtai Technology Co., Ltd.

Vice President & Professor at Central University of Finance and Economics - China

Secretary at Huayi Compressor Co., Ltd.

Director & Executive Deputy General Manager at Jiangxi Fushine Pharmaceutical Co., Ltd.

Secretary & Vice President at China Chengxin Credit Management Co., Ltd.

Director at Jiangxi Fushine Pharmaceutical Co., Ltd.

Subscribe now to see full list of current and former board members
Paths to Jiangxi Fushine Pharmaceutical Co., Ltd.
Potential Connections via
Relationship Science
You
Jiangxi Fushine Pharmaceutical Co., Ltd.
Recent Transactions
Details Hidden

Jiangxi Fushine Pharmaceutical Co., Ltd. issued Class A Common Stock

Details Hidden

Zhejiang Yongtai Technology Co., Ltd. purchases Jiangxi Fushine Pharmaceutical Co., Ltd.

Subscribe now to see full list of recent transations
Transaction Advisors
Underwriter

Advised onJiangxi Fushine Pharmaceutical Co., Ltd. issued Class A Common Stock

Subscribe now to see transaction advisors for over 2.5 million organizations
Subscribe now to see transaction advisors for over 2.5 million organizations
Clients

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and intermediates. Its business areas include: Non-contract manufacturing organization (CMO) business for active pharmaceutical ingredients (APIs) and intermediates, CMO business for APIs and intermediates, and Other. Its products are classified into API commercialized products such as losartan potassium, irbesartan, and valsartan; validated products such as apixaban, azilsartan, bosentan, and cinacalcet hydrochloride; products to be validated/under development such as aliskiren hemifumarate, azilsartan medoxomil, silodosin, and alogliptin benzoate; pharmaceutical intermediates including 2-Cyano-4'-methylbiphenyl, 2-Cyano-4'-bromomethylbiphenyl, and N-(Triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)tetrazole; and fine chemicals such as N,N'- Dicyclohexylcarbodiimide, 1-Ethy-3-(3'-dimethylaminopropyl) carbodiimide hydrochloride, and 2,6-Dichloroaniline. The company was founded on February 14, 2003 and is headquartered in Taizhou, China.

Subscribe now to see clients for over 2.5 million organizations
Subscribe now to see clients for over 2.5 million organizations
Key Stats and Financials As of 2016
Market Capitalization
$4.46B
Total Enterprise Value
$6.33B
Earnings Per Share
$1.61
Revenue
$757M
Net Profit
$174M
EBITDA
$219M
EBITDAMargin
28.91%
Total Debt
$397M
Total Equity
$784M
Enterprise Value Sales
8.37x
Enterprise Value EBITDAOperating
28.95x
TEVNet Income
36.41x
Debt TEV
0.06x
Three Year Compounded Annual Growth Rate Of Revenue
19.68%
Subscribe now to see full financial details
Investors
Details Hidden

Chairman at Jiangxi Fushine Pharmaceutical Co., Ltd.

Details Hidden

Zhejiang Yongtai Technology Co., Ltd. engages in the manufacture of fluorination compounds. Its products include fluorinated nitrobenzene, fluorinated aniline, fluorinated fluorobromobenzene, fluorinated fluorobenzene, fluorinated fluorophenol, penta fluorinate compounds, fluorinated fluorobenzonitrile, fluorinate fluorophenylboronic acid, and other fluorinated intermediate. The company products applied to liquid cyrstal, novel medicines and healthcare products and agrochemical. Zhejiang Yongtai Technology was founded by He Ren Bao and Wang Ying Mei on October 11, 1999 and is headquartered in Taizhou, China.

Details Hidden

Jiuding Capital is an active manager which invests in early-stage unlisted China-based companies operating in a range of sectors including electronics, communications, biotechnology, IT services, new energy, media, manufacturing, services and agricultural chemicals.The firm seeks to invest in well managed companies which are, or have the potential to become industry or regional market leaders. They prefer to participate in LBOs, growth and expansion capital investments, primarily through stock investment.Jiuding Capital typically takes minority stakes in their investee companies and contributes to major decision-making through board of director participation. They partner with their investee companies to provide value-added services including stock market listing assistance (in China or overseas), financial consulting, strategic planning assistance, corporate governance advice, internal structure and profit model optimization, tax planning and legal affairs and overseas marketing services.The firm aims to exit their investments through IPOs.

Subscribe now to see full details